Understanding Benefit Design to Evaluate the Suitability of Cell & Gene Therapies & Propose Novel Solutions

Time: 12:00 pm
day: Conference Day Two


  • Understanding the type of cell and gene therapy products that would meet the characteristics of a strong benefit design spread across commercial and public sectors
  • Should the federal government propose a new standalone benefit for selling gene therapy products?
  • Underscoring the importance of tailoring benefit designs for cell and gene therapies based on their specific characteristics